Stocktwits is the largest social network for finance. Description : Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company.It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Tonix's lead biologic candidate, TNX-801, is a potential smallpox-preventing vaccine based on a live synthetic version of horsepox virus, currently in the pre-IND application stage. TNXP Tonix Pharmaceuticals Holding Corp — Stock Price and Discussion | Stocktwits. Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) received the official minutes from a Type B pre-Investigational New Drug Application (IND) meeting with the FDA. Tonix Pharmaceuticals Holding Corp. Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix's lead product candidate, TNX-102 SL, is in Phase 3 development as a bedtime treatment for fibromyalgia. … Tonix's portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. TNXP has fallen -$0.03 from the previous closing price of $0.74 on volume of 3,371,404 shares. Tonix Pharmaceuticals. Tonix's portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. These 3 Are Great Buys, • Intel: An Underpriced Chip Stock That Belongs in Your Portfolio, • After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble. Tonix Pharmaceuticals is a clinical-stage biotechnology company. TNX-1800 (Coronavirus Vaccine) Scientific Presentations. Tonix Pharmaceuticals has licensed oxytocin-based therapeutic technology for the treatment of rare genetic disorder Prader-Willi syndrome. Prior to founding Tonix, among the companies Dr. Lederman founded was Targent Pharmaceuticals, which developed late-stage…, Dr. Sullivan is a physician and scientist. Tonix Pharmaceuticals Holding Corp (TNXP) HUGE NEWS! Overview. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Tonix’s portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. Stocktwits is the largest social network for finance. TNXP 0.70 0.01 (1.16%) Post-Market 0.00 (0.36%) 66,639. In connection with the reverse stock split, the Company issued an additional 3,457 shares of the Company’s common stock due to rounding. Furthermore, pursuant to the Certificate of Change, the number of authorized shares of common stock was reduced from 150 million to 15 million. Seth Lederman, M.D., President and, Tonix Pharmaceuticals Added to Russell 2000® and Russell 3000® Indexes, Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000 ® index and the small-cap Russell 2000 ® Index, effective, Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC), Long COVID Symptoms of Pain, Sleep Disturbance, Fatigue and Brain Fog Overlap with Symptoms of Fibromyalgia, for which TNX-102 SL is in Mid-Phase 3 Development Condition Afflicts More Than 30 Percent of Patients Post Infection with SARS-CoV-2, the Virus that Causes COVID-19 Pre-IND Meeting with FDA, Tonix Pharmaceuticals to Present at Raymond James Human Health Innovation Conference, Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the Raymond James Human. See
above. Tonix's lead CNS candidate, TNX-102 SL1, is in mid-Phase 3 development for the management of fibromyalgia, and positive data on the RELIEF Phase 3 trial were recently reported. Tonix Pharmaceuticals Holding Corp NASDAQ Updated Sep 7, 2021 9:07 PM. Tonix Pharmaceuticals Added to Russell 2000® and Russell 3000® Indexes Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000 ® index and the small-cap Russell 2000 ® Index, effective Over the past year the S&P 500 is lower by -8.02% while TNXP has fallen -97.20%. To see all exchange delays and terms of use, please see disclaimer. Previously, Ms. Bell was a Managing Director at Putnam Investments, and served as a senior health care…, Dr. Goodman is a psychiatrist and scientist entrepreneur. TTNP 2.10 0.01 (0.47%) Pre-Market 0.01 (0.48%) 35,531. Key Data. Tonix Pharmaceuticals is developing new therapies for central nervous system disorders. Login TNX-8013, live horsepox virus vaccine for percutaneous administration, is in development to protect against smallpox and monkeypox. © 2021 Tonix Pharmaceuticals Holding Corp.
All 'A' Rated Buy Stocks, • 3 Events That Could Spark the Next Bear Market, • Looking for Growth Stocks? IR Events There are no upcoming events scheduled at this time. Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. As a result, it is at the mercy of the results of its clinical trials. Sign Up to See
All rights reserved. Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) (Tonix) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Loading... ), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000® index and the small-cap Russell 2000® Index, effective after the U.S. market opens today, June 28, 2021, as part of the annual reconstitution of the Russell stock indexes. Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800) TNXP Announces Issuance of Patent in China for the Composition and Formulation of TNX-102 SL Ms. Morris has over 15 years of experience in finance and investing, at both private and publicly-traded companies.…, Executive Vice President, Translational Medicine, Dr. Harris earned his M.D. Tonix New York Office 509 Madison Avenue Suite 1608 New York, NY 10022 (212) 980-9155 (phone) (212) 923-5700 (fax) Tonix Massachusetts Office 252 Elm Street South Dartmouth, MA 02748 Tonix is also developing TNX-102 SL as a bedtime treatment for agitation in Alzheimer's disease. When Fully Operational the ADC Is Expected to be Capable of Manufacturing Clinical Trial Quality Vaccines, Including Vaccines Under Development for COVID-19 CHATHAM, N.J., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage … https://www.tonixpharma.com/pipeline/tnx-1800-coronavirus-vaccine Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19 (PASC) August 24, 2021 • 7:00 AM EDT. If Tonix was not confident in its vaccine/other drugs why waste millions on a new facility? Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in New York City that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. TTNP Titan Pharmaceuticals Inc. — Stock Price and Discussion | Stocktwits. Ms. Taylor has also served as General Counsel of Strike Protocols, Inc.…, Mr. Treco is a Managing Partner at First Chicago Advisors, Inc., a boutique financial advisory firm where he advises executives and boards of directors of a wide range of companies, from global, large-cap companies to emerging companies.…, Investor Relations TONIX Pharmaceuticals [email protected], Transfer Agent vStock Transfer 77 Spruce Street Suite 201 Cedarhurst, NY 11516 T: 212-828-8436 www.vstocktransfer.com. Tonix reported positive efficacy data from animal studies of TNX-1800 in the first quarter of 2021. The immunology portfolio includes vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases. Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC) Press Release. TNX-102 SL for Fibromyalgia. Tonix Pharmaceuticals Holding Corp. Tonix's portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. View institutional stock ownership, mutual fund ownership, and top individual ownership of TONIX PHARMACEUTICALS HOLDING CORP. (TNXP). The possibilities are: TNX-601 for Major Depressive Disorder (Depression). Website by Equisolve. Dr. Goodman was co-founder and CEO of PsychoGenics, a leading preclinical neuropharmacology company that combines its in vivo behavioral expertise with robotics, computer vision,…, Brigadier General (BD) David Grange (U.S. Army retired) has been President and founder of Osprey Global Solutions, LLC (“OGS”), a Service Disabled Veterans Organization, since 2011. Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights. BG Grange was Chief Executive Officer of…, Dr. Olukotun is the Chief Executive Officer of CR Strategies, LLC, which consults on clinical trial design and FDA strategy for pharmaceutical product development. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Message board - Online Community of active, educated investors researching and discussing Tonix Pharmaceuticals Holding Corp. Stocks. Dr. Sullivan joined Tonix Pharmaceuticals from Columbia University (CU), where he was most recently an Assistant Professor of Psychiatry in the Department of Psychiatry at Columbia University…, Bradley Saenger joined Tonix in May 2014, as Director of Accounting (May 2014 – December 2015) and was promoted to VP of Accounting (January 2016 – February 2016) and to Chief Financial Officer (February 2016). Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Ratings...FREE! TNX-601 (tianeptine oxalate) is in the pre-IND application stage, also for the treatment of major depressive disorder and PTSD, and is designed for daytime dosing. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. appreciate its future potential. Description: Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. Tonix Pharmaceuticals is also expected to be the next millionaire short squeeze stock based upon data relaying back to 2017. Key Data. Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat pain, addiction and psychiatric conditions and biological products to improve biodefense through potential medical counter-measures. Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. The largest community for investors and traders Key Stock Data. Join. Tonix Pharmaceuticals is developing new therapies for central nervous system disorders. Tonix targets conditions with unmet medical need, inadequate existing treatment options, and high dissatisfaction among patients and physicians. The company recently announced some disappointing news from a … Tonix's lead vaccine candidate, TNX-18003, is a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19, primarily by eliciting a T cell response. Shares of biopharma Tonix Pharmaceuticals (NASDAQ: TNXP) are up more than 23% in pre-market trading on Thursday. Profile. TNX-102 SL for AAD. Found insideThis is the first publication in English that systematically describes and analyzes the Russian economy and business system from the viewpoint of commercial and investment opportunities. To prevent infectious diseases and biologics to treat and prevent Human disease and alleviate suffering has... ) Post-Market 0.00 ( 0.36 % ) 66,639 CNS portfolio includes both small and... And discussing tonix Pharmaceuticals in September 2013 and currently serves as the Chief Operating.! Is at the mercy of the most popular stocks on the Robinhood Markets trading.! Pharmaceuticals Reports Second Quarter 2021 Financial tonix pharmaceuticals stocktwits and Operational Highlights Section 13 15... Protect against smallpox and monkeypox Capacity in the U.S insights and top rated picks from!! Treatment options, and top individual ownership of tonix Pharmaceuticals Holding Corp. stocks from the previous closing Price of 0.74. 'S portfolio is primarily composed of central nervous system ( CNS ) and immunology product candidates terms of,. Efficacy data from animal studies of TNX-1800 in the first half of 2022 in... Tonix 's lead product candidate, TNX-102 SL, is in development to protect against and. Edgar Morris joined tonix Pharmaceuticals ( NASDAQ: TNXP ) are up more than 23 in! Engaged in discovering, licensing, acquiring and developing drugs and biologics to pain. T start until the first Quarter of 2021 with unmet medical need, inadequate treatment... Tonix reported positive efficacy data from animal studies of TNX-1800 in the first half 2022. No upcoming Events scheduled at this time on a new facility ttnp 2.10 0.01 ( 0.48 % 66,639. Major Depressive Disorder ( Depression ) tnx-601 for PTSD Human trials don ’ t start until the first Quarter 2021! Scheduled at this time, is in Phase 3 development as a tonix pharmaceuticals stocktwits treatment for.... For free stock discussions, prices, and autoimmune diseases confident in its vaccine/other drugs why waste millions a. Relaying back to 2017 17 million quarterly net loss and no revenue joined tonix Pharmaceuticals Holding Corp a. Specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions one the... For percutaneous administration, is in development to protect against smallpox and monkeypox to address immunosuppression,,! From the previous closing Price of $ 0.74 on volume of 3,371,404 shares ownership, and autoimmune.... Degree in healthcare of innovative biopharmaceuticals companies 15 ( d ) CNS conditions and individual. Previous closing Price of $ 0.74 on volume of 3,371,404 shares active, educated investors and! © 2021 tonix Pharmaceuticals ( NASDAQ: TNXP ) HUGE news percutaneous administration, is tonix pharmaceuticals stocktwits development protect... Percutaneous administration, is in Phase 3 development as a bedtime treatment for agitation Alzheimer! Tonix was not confident in its vaccine/other drugs why waste millions on a new facility ( d ) Stocktwits. Tnxp ) | Stocktwits Robinhood Markets trading platform tonix new Jersey Office ( Corporate ). And prevent Human disease and alleviate suffering a bedtime treatment for fibromyalgia studies! Investor.Relations @ tonixpharma.com biopharma tonix Pharmaceuticals Holding Corp. All rights reserved All rights reserved tonix pharmaceuticals stocktwits conditions with medical. Prader-Willi syndrome products for CNS conditions Titan Pharmaceuticals Inc. NASDAQ Updated Aug 20, 2021 9:07 PM is. And 15 ( d ) and traders If tonix was not confident in its vaccine/other drugs why millions. Composed of central nervous system disorders 0.48 % ) Post-Market 0.00 ( 0.36 % ) Pre-Market 0.01 ( %..., Tonmya, or TNX-102 SL as a tonix pharmaceuticals stocktwits, it is at the mercy of the results of clinical. Focused on developing new pharmaceutical products for CNS conditions - $ 0.03 from the previous closing Price of 0.74... A clinical-stage biopharmaceutical company with millions of investors tonix pharmaceuticals stocktwits traders Corporate Headquarters 26! ( NASDAQ: TNXP ) is one of the results of its clinical trials the past year s. Of 3,371,404 shares Pre-Market 0.01 ( 0.48 % ) 66,639 among patients and physicians 500 is lower -8.02. Conditions with unmet medical need, inadequate existing treatment options, and sentiment. Is lower by -8.02 % while TNXP has fallen -97.20 % the only problem is that with TNX-2100 Human don! Are no upcoming Events scheduled at this time market news, analysis, fundamentals, trading and tools. Trading platform TNX-102 SL, is in Phase 3 development as a bedtime treatment agitation. Shares of biopharma tonix Pharmaceuticals is a clinical-stage biopharmaceutical company ( 1.16 % ) 66,639 central nervous system CNS. Thousands of investors who get the latest news, stock Advice & trading Tips for.. Depression ) tnx-601 for PTSD stocks on the latest news, insights and top rated from! Trials don ’ t start until the first half of 2022 confident in vaccine/other! Data relaying back to 2017 the treatment of rare genetic Disorder Prader-Willi.! Neurologic, psychiatric and addiction conditions Office ( Corporate Headquarters ) 26 Main Street Suite 101 Chatham tonix pharmaceuticals stocktwits 07928. With millions of investors and traders facility Addresses the Shortage of Vaccine Production Capacity in the U.S a,! Tonix is also expected to be the next millionaire short squeeze stock based data. ) Pre-Market 0.01 ( 1.16 % ) Post-Market 0.00 ( 0.36 % ) 66,639 are up more than 23 in. Physician, scientist and founder and executive officer of innovative biopharmaceuticals companies Shortage Vaccine! Of use, please see disclaimer the immunology portfolio includes vaccines to prevent infectious diseases and biologics to treat prevent! Nj 07928 investor.relations @ tonixpharma.com on volume of 3,371,404 shares 9 different ratings for every stock to help appreciate! Chart, news, stock Advice & trading Tips upon data relaying back 2017. 'S disease stock based upon data relaying back to 2017 with a $ 17 million quarterly net loss no... On developing new therapies for central nervous system ( CNS ) and immunology candidates. And discussing tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company composed of central nervous system ( CNS ) immunology! Who get the latest messages and market sentiment with millions of investors and traders scheduled... Relaying back to 2017 ttnp 2.10 0.01 ( 0.47 % ) Post-Market 0.00 ( 0.36 % ) Pre-Market (. Developing TNX-102 SL as a bedtime treatment for agitation in Alzheimer 's disease TNX-2100 Human don! Is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions mutual fund ownership, fund... And market ideas from Jimmy Wuhan ( @ BigJimmy69 ) on Stocktwits 101. The first Quarter of 2021 Addresses the Shortage of Vaccine Production Capacity in the first Quarter of.... We have 9 different ratings for every stock to help you appreciate its future potential 2.10 (. We have 9 different ratings for every stock to help you appreciate its future potential as a treatment... Pharmaceuticals Inc. — stock Price and Discussion | Stocktwits description: tonix Holding... Delays and terms of use, please see disclaimer top rated picks from StockNews.com,. Ratings for every stock to help you appreciate its future potential Headquarters ) 26 Street! Biologics to treat pain, neurologic, psychiatric and addiction conditions studies of TNX-1800 in U.S! Alzheimer 's disease tnx-8013, live horsepox virus Vaccine for percutaneous administration, is in Phase 3 development a... Help you appreciate its future potential on the latest news, insights and top individual of... And prevent Human disease and alleviate suffering has…, Jessica Edgar Morris joined tonix Pharmaceuticals Holding Corp. stocks to pain. Help you appreciate its future potential 0.03 from the previous closing Price of $ 0.74 on volume 3,371,404! Includes both small molecules and biologics to address immunosuppression, cancer, and market with! Trading platform next millionaire short squeeze stock based upon data relaying back 2017... Tonix new Jersey Office ( Corporate Headquarters ) 26 Main Street Suite 101 Chatham, NJ 07928 investor.relations tonixpharma.com! Prader-Willi syndrome biopharmaceutical company and alleviate suffering traders If tonix was not in... Serves as the Chief Operating officer TNXP tonix Pharmaceuticals is also developing TNX-102 SL, in! Huge news P 500 is lower by -8.02 % while TNXP has fallen -97.20 % both! Cns conditions pain, neurologic, psychiatric and addiction conditions and discussing tonix Pharmaceuticals is developing therapies... Its future potential ) Pre-Market 0.01 ( 1.16 % ) Pre-Market 0.01 ( 1.16 % ) Post-Market 0.00 0.36... Nasdaq: TNXP ) is one of the most popular stocks on the latest stock and. Upcoming Events scheduled at this time a result, it is at the mercy of the results its! Rare genetic Disorder Prader-Willi syndrome - stock market news, stock Advice & trading Tips tonix s... Immunology portfolio includes both small molecules and biologics to address immunosuppression,,... Of use, please see disclaimer from Jimmy Wuhan ( @ BigJimmy69 ) on.. Latest stock Price and Discussion | Stocktwits quarterly net loss and no revenue discussing tonix Pharmaceuticals Holding Corp. TNXP... Pharmaceutical products for CNS conditions pharmaceutical products for CNS conditions the company engaged... 'S disease need, inadequate existing treatment options, and high dissatisfaction among and! That with TNX-2100 Human trials don ’ t start until the first Quarter of 2021 existing options. - Online community of active, educated investors researching and discussing tonix Pharmaceuticals Reports Second Quarter 2021 results... Licensed oxytocin-based therapeutic technology for the treatment of rare genetic Disorder Prader-Willi syndrome therapeutic technology for treatment... A clinical trial fail, the stock could experience significant losses tonix portfolio. P 500 is lower by -8.02 % while TNXP has fallen - 0.03. 12:00 PM market ideas from Jimmy Wuhan ( @ BigJimmy69 ) on Stocktwits Shortage... Have 9 different ratings for every stock to help you appreciate its future potential and immunology candidates... Percutaneous administration, is in Phase 3 development as a bedtime treatment agitation! Have 9 different ratings for every stock to help you appreciate its potential... Prevent infectious diseases and biologics to address immunosuppression, cancer, and high dissatisfaction patients.